These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26022903)

  • 1. Influence of Iron Overload on Immunosuppressive Therapy in Children with Severe Aplastic Anemia.
    Pawelec K; Salamonowicz M; Panasiuk A; Leszczynska E; Krawczuk-Rybak M; Demkow U; Matysiak M
    Adv Exp Med Biol; 2015; 866():83-9. PubMed ID: 26022903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload.
    Kim IH; Moon JH; Lim SN; Sohn SK; Kim HG; Lee GW; Kim YS; Lee HS; Kwon KY; Kim SH; Park KT; Chung JS; Lee WS; Lee SM; Hyun MS; Kim H; Ryoo HM; Bae SH; Joo YD
    Transfusion; 2015 Jul; 55(7):1613-20. PubMed ID: 25764017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
    Chen C; Fang JP; Huang SL; Zhong FY
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
    Jalaeikhoo H; Khajeh-Mehrizi A
    PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.
    Cheong JW; Kim HJ; Lee KH; Yoon SS; Lee JH; Park HS; Kim HY; Shim H; Seong CM; Kim CS; Chung J; Hyun MS; Jo DY; Jung CW; Sohn SK; Yoon HJ; Kim BS; Joo YD; Park CY; Min YH;
    Transfusion; 2014 Jun; 54(6):1542-51. PubMed ID: 24313463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in hematopoiesis after iron chelation therapy with deferasirox in patients with aplastic anemia.
    Lee SE; Yahng SA; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Acta Haematol; 2013; 129(2):72-7. PubMed ID: 23154600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of immunosupressive therapy in children with severe aplastic anaemia. Report of the Polish Paediatric Haematology Group].
    Pawelec K; Matysiak M; Niewiadomska E; Rokicka-Milewska R; Kowalczyk J; Stefaniak J; Balwierz W; Załecka-Czerpko E; Chybicka A; Szmyd K; Sońta-Jakimczyk D; Bubała H; Krauze A; Wysocki M; Kurylak A; Wachowiak J; Grund G; Młynarski W; Bulas M; Krawczuk-Rybak M; Leszczyńska E; Urasiński T; Peregud-Pogorzelski J; Balcerska A; Włazłowski M
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1092-7. PubMed ID: 19531832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATG-Fresenius S combined with cyclosporine a: an effective immunosuppressive therapy for children with aplastic anemia.
    Luo CJ; Gao YJ; Tang JY; Zhu XH; Xue HL; Lu FJ; Pan C; Jiang H; Luo CY; Ye QD; Zhou M; Chen J
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):374-8. PubMed ID: 24807005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
    Pongtanakul B; Das PK; Charpentier K; Dror Y
    Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of immunosuppressive therapy in children with severe aplastic anaemia. Report by the Polish Paediatric Leukaemia and Lymphoma Study Group].
    Pawelec K; Matysiak M; Niewiadomska E; Rokicka-Milewska R; Kowalczyk J; Stefaniak J; Balwierz W; Załecka-Czepko E; Chybicka A; Szmyd K; Sońta-Jakimczyk D; Bubała H; Krauze A; Wysocki M; Kurylak A; Wachowiak J; Kaczmarek-Kanold M; Stolarska M; Karolczyk I; Krawczuk-Rybak M; Leszczyńska E; Urasiński T; Peregud-Pogorzelski J; Balcerska A; Włazłowski M
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):832-9. PubMed ID: 17317914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on abnormal iron metabolism and iron overload in patients with aplastic anemia].
    Jin P; Shi J; Li XX; Shao YQ; Nie N; Ge ML; Zhang J; Huang ZD; Huang JB; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):877-82. PubMed ID: 24171963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
    Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
    Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].
    Huang YL; Huang SL; Huang K; Bao R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.
    Takatoku M; Uchiyama T; Okamoto S; Kanakura Y; Sawada K; Tomonaga M; Nakao S; Nakahata T; Harada M; Murate T; Ozawa K;
    Eur J Haematol; 2007 Jun; 78(6):487-94. PubMed ID: 17391310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine.
    Fang JP; Xu HG; Huang SL; Chen C; Huang K
    Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line immunosuppressive treatment in children with aplastic anemia: rabbit antithymocyte globulin.
    Pawelec K; Salamonowicz M; Panasiuk A; Demkow U; Kowalczyk J; Balwierz W; Zaleska-Czepko E; Chybicka A; Szmyd K; Szczepanski T; Bubala H; Wysocki M; Kurylak A; Wachowiak J; Szpecht D; Młynarski W; Bulas M; Krawczuk-Rybak M; Leszczynska E; Urasinski T; Peregud-Pogorzelski J; Balcerska A; Kaczorowska-Hac B; Matysiak M
    Adv Exp Med Biol; 2015; 836():55-62. PubMed ID: 25310948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
    Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
    Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Significance of Elevated Serum Ferritin Levels Prior to Transplantation in Patients With Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation (autoHSCT): Role of Iron Overload.
    Sivgin S; Karamustafaoglu MF; Yildizhan E; Zararsiz G; Kaynar L; Eser B; Cetin M; Unal A
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S152-8. PubMed ID: 27521313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.